Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic

Lindsay Lai1, Filippos Michopoulos, Helen Gika

  • 1Dept of Drug Metabolism and Pharmacokinetics, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK.

Molecular Biosystems
|December 22, 2009
PubMed

Related Concept Videos